It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The S. pyogenes (Sp) Cas9 endonuclease is an important gene-editing tool. SpCas9 is directed to target sites based on complementarity to a complexed single-guide RNA (sgRNA). However, SpCas9-sgRNA also binds and cleaves genomic off-targets with only partial complementarity. To date, we lack the ability to predict cleavage and binding activity quantitatively, and rely on binary classification schemes to identify strong off-targets. We report a quantitative kinetic model that captures the SpCas9-mediated strand-replacement reaction in free-energy terms. The model predicts binding and cleavage activity as a function of time, target, and experimental conditions. Trained and validated on high-throughput bulk-biochemical data, our model predicts the intermediate R-loop state recently observed in single-molecule experiments, as well as the associated conversion rates. Finally, we show that our quantitative activity predictor can be reduced to a binary off-target classifier that outperforms the established state-of-the-art. Our approach is extensible, and can characterize any CRISPR-Cas nuclease – benchmarking natural and future high-fidelity variants against SpCas9; elucidating determinants of CRISPR fidelity; and revealing pathways to increased specificity and efficiency in engineered systems.
Cas9 off-target sites can be predicted by many bioinformatics tools. Here the authors present low complexity mechanistic model that characterizes SpCas9 kinetics in free-energy terms, allowing quantitative prediction of off-target activity in bulk-biochemistry, single molecule, and whole-genome profiling experiments.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details






1 Delft University of Technology, Kavli Institute of NanoScience and Department of BionanoScience, Delft, the Netherlands (GRID:grid.5292.c) (ISNI:0000 0001 2097 4740); TNO Building and Construction Research, Dept. Building Physics and Systems, Delft, The Netherlands (GRID:grid.4858.1) (ISNI:0000 0001 0208 7216)
2 Delft University of Technology, Kavli Institute of NanoScience and Department of BionanoScience, Delft, the Netherlands (GRID:grid.5292.c) (ISNI:0000 0001 2097 4740); Vrije Universiteit Amsterdam, Department of Physics and Astronomy, and LaserLaB Amsterdam, Amsterdam, the Netherlands (GRID:grid.12380.38) (ISNI:0000 0004 1754 9227)
3 Delft University of Technology, Kavli Institute of NanoScience and Department of BionanoScience, Delft, the Netherlands (GRID:grid.5292.c) (ISNI:0000 0001 2097 4740)
4 University of Texas at Austin, Department of Molecular Biosciences, Austin, USA (GRID:grid.89336.37) (ISNI:0000 0004 1936 9924); University of Texas at Austin, Institute for Cellular and Molecular Biology, Austin, USA (GRID:grid.89336.37) (ISNI:0000 0004 1936 9924); University of Texas at Austin, Center for Systems and Synthetic Biology, Austin, USA (GRID:grid.89336.37) (ISNI:0000 0004 1936 9924); Vilnius University, VU LSC-EMBL Partnership for Genome Editing Technologies, Life Sciences Center, Vilnius, Lithuania (GRID:grid.6441.7) (ISNI:0000 0001 2243 2806)
5 University of Texas at Austin, Department of Molecular Biosciences, Austin, USA (GRID:grid.89336.37) (ISNI:0000 0004 1936 9924); University of Texas at Austin, Institute for Cellular and Molecular Biology, Austin, USA (GRID:grid.89336.37) (ISNI:0000 0004 1936 9924); University of Texas at Austin, Center for Systems and Synthetic Biology, Austin, USA (GRID:grid.89336.37) (ISNI:0000 0004 1936 9924); University of Texas at Austin, Oden Institute for Computational Engineering and Science, Austin, USA (GRID:grid.89336.37) (ISNI:0000 0004 1936 9924); European Molecular Biology Laboratory, Genome Biology Department, Heidelberg, Germany (GRID:grid.4709.a) (ISNI:0000 0004 0495 846X)
6 University of Texas at Austin, Department of Molecular Biosciences, Austin, USA (GRID:grid.89336.37) (ISNI:0000 0004 1936 9924); University of Texas at Austin, Institute for Cellular and Molecular Biology, Austin, USA (GRID:grid.89336.37) (ISNI:0000 0004 1936 9924); University of Texas at Austin, Center for Systems and Synthetic Biology, Austin, USA (GRID:grid.89336.37) (ISNI:0000 0004 1936 9924)